| Key Financial Ratios of Marksans Pharma (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
0.93 |
1.07 |
0.30 |
0.28 |
1.75 |
|
| Diluted EPS (Rs.) |
0.93 |
1.07 |
0.30 |
0.28 |
1.75 |
|
| Cash EPS (Rs.) |
1.21 |
1.28 |
0.60 |
0.65 |
2.11 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
12.35 |
11.50 |
10.48 |
10.23 |
10.02 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
12.35 |
11.50 |
10.48 |
10.23 |
10.02 |
|
| Dividend / Share(Rs.) |
0.10 |
0.05 |
0.05 |
0.05 |
0.12 |
|
| Revenue from Operations/Share (Rs.) |
10.59 |
10.36 |
7.20 |
5.27 |
8.75 |
|
| PBDIT/Share (Rs.) |
1.75 |
1.74 |
0.89 |
0.77 |
2.75 |
|
| PBIT/Share (Rs.) |
1.47 |
1.53 |
0.59 |
0.40 |
2.39 |
|
| PBT/Share (Rs.) |
1.29 |
1.37 |
0.41 |
0.29 |
2.24 |
|
| Net Profit/Share (Rs.) |
0.93 |
1.07 |
0.30 |
0.28 |
1.75 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
16.53 |
16.80 |
12.41 |
14.56 |
31.43 |
|
| PBIT Margin (%) |
13.84 |
14.75 |
8.25 |
7.61 |
27.31 |
|
| PBT Margin (%) |
12.16 |
13.20 |
5.65 |
5.53 |
25.58 |
|
| Net Profit Margin (%) |
8.74 |
10.28 |
4.21 |
5.34 |
19.96 |
|
| Return on Networth / Equity (%) |
7.49 |
9.26 |
2.89 |
2.75 |
17.42 |
|
| Return on Capital Employed (%) |
11.31 |
12.79 |
5.45 |
3.76 |
16.89 |
|
| Return on Assets (%) |
6.31 |
7.12 |
2.22 |
2.11 |
13.38 |
|
| Total Debt/Equity (X) |
0.00 |
0.16 |
0.15 |
0.17 |
0.10 |
|
| Asset Turnover Ratio (%) |
72.26 |
69.30 |
52.87 |
39.54 |
67.04 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
3.52 |
2.21 |
2.09 |
1.98 |
1.84 |
|
| Quick Ratio (X) |
2.44 |
1.64 |
1.71 |
1.71 |
1.44 |
|
| Inventory Turnover Ratio (X) |
5.81 |
6.03 |
6.97 |
7.38 |
8.19 |
|
| Dividend Payout Ratio (NP) (%) |
6.50 |
4.69 |
19.82 |
51.20 |
8.09 |
|
| Dividend Payout Ratio (CP) (%) |
4.97 |
3.91 |
9.98 |
22.26 |
6.71 |
|
| Earnings Retention Ratio (%) |
93.50 |
95.31 |
80.18 |
48.80 |
91.91 |
|
| Cash Earnings Retention Ratio (%) |
95.03 |
96.09 |
90.02 |
77.74 |
93.29 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
565.59 |
1,102.67 |
1,371.07 |
2,011.58 |
1,941.02 |
|
| EV/Net Operating Revenue (X) |
1.30 |
2.60 |
4.65 |
9.32 |
5.42 |
|
| EV/EBITDA (X) |
7.89 |
15.47 |
37.49 |
63.98 |
17.24 |
|
| MarketCap/Net Operating Revenue (X) |
1.31 |
2.40 |
4.40 |
8.94 |
5.28 |
|
| Retention Ratios (%) |
93.49 |
95.30 |
80.17 |
48.79 |
91.90 |
|
| Price/BV (X) |
1.13 |
2.16 |
3.02 |
4.61 |
4.61 |
|
| Price/Net Operating Revenue |
1.31 |
2.40 |
4.40 |
8.94 |
5.28 |
|
| Earnings Yield |
0.07 |
0.04 |
0.01 |
0.01 |
0.04 |
|
Source : Dion Global Solutions Limited
